Novel nucleases with diverse properties represent promising solutions, emphasizing their potential to overcome current limitations in genome editing and therapeutic delivery.
Monika Paulė
Advertisement
Monika Paulė, PhD, is chief executive officer at Caszyme.
Articles by Monika Paulė
Advertisement
Latest Updated Articles
Advertisement
Advertisement